Longevity Investors Conference

Startseite
Schweiz
Zug
Longevity Investors Conference

Creating premier platforms for the most prominent investors in the longevity field.│Join the Longevity Investors Conference, Sept 22-25 in Gstaad!

02/06/2026

Matt Cooper has backed 45+ longevity companies.
Scotch McClure is moving rejuvenation science from hypothesis to clinic.
A Swiss private bank built for generational wealth now calls longevity the allocation question of the decade.
Exceptional Ventures, Maxwell Biosciences, and Maerki Baumann & Co. AG. A venture builder, a science platform, and a steward of generational capital, each backing the conviction that longer, healthier lives are now investable.

Good partners make for sharper conversations.

01/06/2026

Early Bird closes tonight.

LIC 2026 - Gstaad, 14-17 September.

Up to 120 investors, family offices, and operators alongside 30+ leading scientists, founders, and industry experts in an application-only setting at Le Grand Bellevue.
Confirmed speakers include Dave Asprey, Dr. Aubrey de Grey, Dr. Nir Barzilai, Dr. Steve Horvath, Michael Ringel (COO, Life Biosciences), Garri Zmudze (LongeVC), Matt Cooper (Exceptional Ventures), Dr. Adeel Khan, and Dr. Collin Ewald.

Link in bio.Apply: longevityinvestors.ch/lic-2026

29/05/2026

Retro Biosciences: $180M to $1.18B+ at a $1.8B valuation. Retro featured at LIC 2025.

: largest Hong Kong biotech IPO of the year, with Eli Lilly and Tencent as cornerstones. of LongeVC, one of Insilico's earliest backers, joins LIC 2026.

Eli Lilly invested directly in NewLimit at a $1.62B valuation. One of the first direct equity positions by a top-five pharma in a cellular reprogramming asset.
Life Biosciences received FDA IND clearance for ER-100, the first cellular rejuvenation therapy using epigenetic reprogramming cleared for human trials. Michael Ringel, COO, joins LIC 2026.

And three new entrants now sit in the top ten: ($11B), ($2.5B), ($1.8B).

Full analysis on longevityinvestorsnews.ch
Applications for LIC 2026 in Gstaad (14-17 September) are open. Early Bird closes 31 May.

26/05/2026

A panel on what it takes to build a longevity company to global scale, with four people who have done exactly that.

(LongeVC, exits in , Basepaws, Deep Longevity).
Masha Bucher (Day One Ventures, $52.5M fund, twelve unicorns).
Anna Skaya (founder of AniVC, built Basepaws to Zoetis acquisition).
(COO Life Biosciences, Board US).

The session: Sustainable Leading Global Enterprise Rooted in Longevity Science and Technology - How?

What scales, what fails, where the infrastructure gaps are.
LIC 2026. Gstaad. 14-17 September. Application-only.

Early Bird pricing closes 31 May. Link in bio.

25/05/2026

What if the science and the capital finally spoke the same language?
asprey. . Steve Horvath. Nir Barzilai. .akhan. .ewald..

30+ speakers. One for every four attendees.
Sessions on the 100-year investment blueprint, what is actually happening in stem cell and peptide clinics, and the scientific bets that will define the next decade.

LIC 2026. Le Grand Bellevue, Gstaad. 14-17 September.
Application-only. Early Bird pricing closes 31 May. Link in bio.

22/05/2026

Twenty years studying the molecular mechanisms of aging. FMI, Harvard, ETH Zürich. Now building regenerative pharmacological interventions for age-related disease at Novartis Biomedical Research.
Founder of the Swiss Society for Aging Research. Top 1000 Longevity Leader globally.

Dr. .ewald Ewald joins LIC 2026 in Gstaad this September.

9 days left to apply at Early Bird pricing. Price moves 31 May.
Learn more: www.longevityinvestors.ch/lic-2026

19/05/2026

.akhan was the first physician to combine multiple advanced cell therapies in clinical practice - years before the approach became standard.

His work today: stem cell technology, peptide therapy, regenerative medicine, precision diagnostics. Protocols that address the root causes of aging at the cellular level.

Founder of Eterna Health. The physician royalty, world-champion athletes, and figures like and worth choose when other care has run its course.

He joins LIC 2026 in Gstaad this September.
Early Bird applications close 31 May. Link in bio.

15/05/2026

When investors ask "who actually decides where longevity capital goes next," there is a short list of people. Michael Ringel is on it.

He runs operations at Life Biosciences, David Sinclair's clinical-stage longevity company, which entered first-in-human trials in 2026. He also sits on the board of the Hevolution Foundation US, which deploys roughly one billion dollars annually into longevity research.

Operator at one of the most-watched longevity companies. Capital-allocation seat at one of the largest longevity funders in the world.

He joins LIC 2026 in Gstaad this September.

Early Bird applications close 31 May.

12/05/2026

Dave Asprey. Aubrey de Grey. Steve Horvath. Nir Barzilai.
Michael Ringel. Natalie Lefevre. Masha Bucher. Collin Ewald. Anna Skaya. Garri Zmudze. Jonathan Anomaly. Evelyne Bischof. Adeel Khan. Philipp Gut. Natalie Coles. Jordan Shlain. Sherry Zhang. David Barzilai.

More to follow.

LIC 2026. Gstaad. 14-17 September.

Application-only. Early Bird pricing ends 31 May.
www.longevityinvestors.ch/lic-2026

08/05/2026

You can't fake operator pattern recognition.

Anna Skaya built Basepaws and exited to Zoetis in 2022. Now General Partner at AniVC, backing animal health and longevity startups. Board, Petco Foundation.

Operator-investor at the edge where longevity actually commercialises.

She joins LIC 2026 in Gstaad this September.
Early Bird applications close 31 May.
Apply: www.longevityinvestors.ch/lic-2026

Adresse

Bahnhofplatz
Zug
6300

Webseite

https://www.longevityinvestors.ch/

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von Longevity Investors Conference erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.